Erik A. Imel

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects

Y. Yamazaki, Akihiro Imura, Itaru Urakawa et al. · Biochemical and Biophysical Research Communications · 2010 · 496 citations · Full text

Life Sciences, Biochemistry, Clinical Biochemistry +6

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis

Shoji Ichikawa, Erik A. Imel, Mary L. Kreiter et al. · Journal of Clinical Investigation · 2007 · 477 citations · Full text

Life Sciences, Biochemistry, Genetics +17

Burosumab Therapy in Children with X-Linked Hypophosphatemia

Thomas O. Carpenter, Michael P. Whyte, Erik A. Imel et al. · New England Journal of Medicine · 2018 · 473 citations · Full text

Medicine, Endocrinology, Nephrology +17

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

Erik A. Imel, Francis H. Glorieux, Michael P. Whyte et al. · The Lancet · 2019 · 367 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +4

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Karl Insogna, Karine Briot, Erik A. Imel et al. · Journal of Bone and Mineral Research · 2018 · 340 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17